author_facet Parekh, Niyati
Lin, Yong
Vadiveloo, Maya
Hayes, Richard B.
Lu-Yao, Grace L.
Parekh, Niyati
Lin, Yong
Vadiveloo, Maya
Hayes, Richard B.
Lu-Yao, Grace L.
author Parekh, Niyati
Lin, Yong
Vadiveloo, Maya
Hayes, Richard B.
Lu-Yao, Grace L.
spellingShingle Parekh, Niyati
Lin, Yong
Vadiveloo, Maya
Hayes, Richard B.
Lu-Yao, Grace L.
Cancer Epidemiology, Biomarkers & Prevention
Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
Oncology
Epidemiology
author_sort parekh, niyati
spelling Parekh, Niyati Lin, Yong Vadiveloo, Maya Hayes, Richard B. Lu-Yao, Grace L. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-13-0330 <jats:title>Abstract</jats:title> <jats:p>Background: Obesity-related dysregulation of the insulin–glucose axis is hypothesized in carcinogenesis. We studied impaired fasting glucose (IFG) and other markers of insulin–glucose metabolism in the Framingham Heart Study-Offspring Cohort, which uniquely tracks these markers and cancer &amp;gt;37 years.</jats:p> <jats:p>Methods: Participants were recruited between 1971 and 1975 and followed until 2008 (n = 4,615; mean age 66.8 years in 2008). Serum glucose, insulin, and hemoglobin A1c were determined from fasting blood in quart-annual exams. Lifestyle and demographic information was self-reported. HRs and 95% confidence intervals (CI) of cancer risk were computed using time-dependent survival analysis (SASv9.3), while accounting for temporal changes for relevant variables.</jats:p> <jats:p>Results: We identified 787 obesity-related cancers, including 136 colorectal, 217 breast, and 219 prostate cancers. Absence versus presence of IFG 10 to 20 years and 20+ years before the event or last follow-up was associated with 44% (95% CI, 1.15–1.79) and 57% (95% CI, 1.17–2.11) increased risk of obesity-related cancers, respectively. When time-dependent variables were used, after adjusting for age, sex, smoking, alcohol, and body mass index, IFG was associated with a 27% increased risk of obesity-related cancer (HR = 1.27; CI, 1.1–1.5). Associations were stronger in smokers (HR = 1.41; CI, 1.13–1.76). Increased risk was noted among persons with higher insulin (HR = 1.47; CI, 1.15–1.88) and hemoglobin A1c (HR = 1.54; CI, 1.13–2.10) for the highest (≥5.73%) versus lowest (≤5.25%) category. A &amp;gt;2-fold increase in colorectal cancer risk was observed for all blood biomarkers of insulin–glucose metabolism, particularly with earlier IFG exposure. Nonsignificant increased risk of breast and prostate cancer was observed for blood biomarkers.</jats:p> <jats:p>Conclusions: Earlier IFG exposure (&amp;gt;10 years before) increased obesity-related cancer risk, particularly for colorectal cancer.</jats:p> <jats:p>Impact: Our study explicitly recognizes the importance of prolonged IFG exposure in identifying links between glucose dysregulation and obesity-related cancers. Cancer Epidemiol Biomarkers Prev; 22(10); 1825–36. ©2013 AACR.</jats:p> Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008) Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-13-0330
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAzMzA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAzMzA
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Association for Cancer Research (AACR), 2013
imprint_str_mv American Association for Cancer Research (AACR), 2013
issn 1538-7755
1055-9965
issn_str_mv 1538-7755
1055-9965
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str parekh2013metabolicdysregulationoftheinsulinglucoseaxisandriskofobesityrelatedcancersintheframinghamheartstudyoffspringcohort19712008
publishDateSort 2013
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_unstemmed Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_full Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_fullStr Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_full_unstemmed Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_short Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_sort metabolic dysregulation of the insulin–glucose axis and risk of obesity-related cancers in the framingham heart study-offspring cohort (1971–2008)
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-13-0330
publishDate 2013
physical 1825-1836
description <jats:title>Abstract</jats:title> <jats:p>Background: Obesity-related dysregulation of the insulin–glucose axis is hypothesized in carcinogenesis. We studied impaired fasting glucose (IFG) and other markers of insulin–glucose metabolism in the Framingham Heart Study-Offspring Cohort, which uniquely tracks these markers and cancer &amp;gt;37 years.</jats:p> <jats:p>Methods: Participants were recruited between 1971 and 1975 and followed until 2008 (n = 4,615; mean age 66.8 years in 2008). Serum glucose, insulin, and hemoglobin A1c were determined from fasting blood in quart-annual exams. Lifestyle and demographic information was self-reported. HRs and 95% confidence intervals (CI) of cancer risk were computed using time-dependent survival analysis (SASv9.3), while accounting for temporal changes for relevant variables.</jats:p> <jats:p>Results: We identified 787 obesity-related cancers, including 136 colorectal, 217 breast, and 219 prostate cancers. Absence versus presence of IFG 10 to 20 years and 20+ years before the event or last follow-up was associated with 44% (95% CI, 1.15–1.79) and 57% (95% CI, 1.17–2.11) increased risk of obesity-related cancers, respectively. When time-dependent variables were used, after adjusting for age, sex, smoking, alcohol, and body mass index, IFG was associated with a 27% increased risk of obesity-related cancer (HR = 1.27; CI, 1.1–1.5). Associations were stronger in smokers (HR = 1.41; CI, 1.13–1.76). Increased risk was noted among persons with higher insulin (HR = 1.47; CI, 1.15–1.88) and hemoglobin A1c (HR = 1.54; CI, 1.13–2.10) for the highest (≥5.73%) versus lowest (≤5.25%) category. A &amp;gt;2-fold increase in colorectal cancer risk was observed for all blood biomarkers of insulin–glucose metabolism, particularly with earlier IFG exposure. Nonsignificant increased risk of breast and prostate cancer was observed for blood biomarkers.</jats:p> <jats:p>Conclusions: Earlier IFG exposure (&amp;gt;10 years before) increased obesity-related cancer risk, particularly for colorectal cancer.</jats:p> <jats:p>Impact: Our study explicitly recognizes the importance of prolonged IFG exposure in identifying links between glucose dysregulation and obesity-related cancers. Cancer Epidemiol Biomarkers Prev; 22(10); 1825–36. ©2013 AACR.</jats:p>
container_issue 10
container_start_page 1825
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 22
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792343247223259137
geogr_code not assigned
last_indexed 2024-03-01T16:48:40.072Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Metabolic+Dysregulation+of+the+Insulin%E2%80%93Glucose+Axis+and+Risk+of+Obesity-Related+Cancers+in+the+Framingham+Heart+Study-Offspring+Cohort+%281971%E2%80%932008%29&rft.date=2013-10-01&genre=article&issn=1538-7755&volume=22&issue=10&spage=1825&epage=1836&pages=1825-1836&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Metabolic+Dysregulation+of+the+Insulin%E2%80%93Glucose+Axis+and+Risk+of+Obesity-Related+Cancers+in+the+Framingham+Heart+Study-Offspring+Cohort+%281971%E2%80%932008%29&aulast=Lu-Yao&aufirst=Grace+L.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-13-0330&rft.language%5B0%5D=eng
SOLR
_version_ 1792343247223259137
author Parekh, Niyati, Lin, Yong, Vadiveloo, Maya, Hayes, Richard B., Lu-Yao, Grace L.
author_facet Parekh, Niyati, Lin, Yong, Vadiveloo, Maya, Hayes, Richard B., Lu-Yao, Grace L., Parekh, Niyati, Lin, Yong, Vadiveloo, Maya, Hayes, Richard B., Lu-Yao, Grace L.
author_sort parekh, niyati
container_issue 10
container_start_page 1825
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 22
description <jats:title>Abstract</jats:title> <jats:p>Background: Obesity-related dysregulation of the insulin–glucose axis is hypothesized in carcinogenesis. We studied impaired fasting glucose (IFG) and other markers of insulin–glucose metabolism in the Framingham Heart Study-Offspring Cohort, which uniquely tracks these markers and cancer &amp;gt;37 years.</jats:p> <jats:p>Methods: Participants were recruited between 1971 and 1975 and followed until 2008 (n = 4,615; mean age 66.8 years in 2008). Serum glucose, insulin, and hemoglobin A1c were determined from fasting blood in quart-annual exams. Lifestyle and demographic information was self-reported. HRs and 95% confidence intervals (CI) of cancer risk were computed using time-dependent survival analysis (SASv9.3), while accounting for temporal changes for relevant variables.</jats:p> <jats:p>Results: We identified 787 obesity-related cancers, including 136 colorectal, 217 breast, and 219 prostate cancers. Absence versus presence of IFG 10 to 20 years and 20+ years before the event or last follow-up was associated with 44% (95% CI, 1.15–1.79) and 57% (95% CI, 1.17–2.11) increased risk of obesity-related cancers, respectively. When time-dependent variables were used, after adjusting for age, sex, smoking, alcohol, and body mass index, IFG was associated with a 27% increased risk of obesity-related cancer (HR = 1.27; CI, 1.1–1.5). Associations were stronger in smokers (HR = 1.41; CI, 1.13–1.76). Increased risk was noted among persons with higher insulin (HR = 1.47; CI, 1.15–1.88) and hemoglobin A1c (HR = 1.54; CI, 1.13–2.10) for the highest (≥5.73%) versus lowest (≤5.25%) category. A &amp;gt;2-fold increase in colorectal cancer risk was observed for all blood biomarkers of insulin–glucose metabolism, particularly with earlier IFG exposure. Nonsignificant increased risk of breast and prostate cancer was observed for blood biomarkers.</jats:p> <jats:p>Conclusions: Earlier IFG exposure (&amp;gt;10 years before) increased obesity-related cancer risk, particularly for colorectal cancer.</jats:p> <jats:p>Impact: Our study explicitly recognizes the importance of prolonged IFG exposure in identifying links between glucose dysregulation and obesity-related cancers. Cancer Epidemiol Biomarkers Prev; 22(10); 1825–36. ©2013 AACR.</jats:p>
doi_str_mv 10.1158/1055-9965.epi-13-0330
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAzMzA
imprint American Association for Cancer Research (AACR), 2013
imprint_str_mv American Association for Cancer Research (AACR), 2013
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1538-7755, 1055-9965
issn_str_mv 1538-7755, 1055-9965
language English
last_indexed 2024-03-01T16:48:40.072Z
match_str parekh2013metabolicdysregulationoftheinsulinglucoseaxisandriskofobesityrelatedcancersintheframinghamheartstudyoffspringcohort19712008
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 1825-1836
publishDate 2013
publishDateSort 2013
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Parekh, Niyati Lin, Yong Vadiveloo, Maya Hayes, Richard B. Lu-Yao, Grace L. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-13-0330 <jats:title>Abstract</jats:title> <jats:p>Background: Obesity-related dysregulation of the insulin–glucose axis is hypothesized in carcinogenesis. We studied impaired fasting glucose (IFG) and other markers of insulin–glucose metabolism in the Framingham Heart Study-Offspring Cohort, which uniquely tracks these markers and cancer &amp;gt;37 years.</jats:p> <jats:p>Methods: Participants were recruited between 1971 and 1975 and followed until 2008 (n = 4,615; mean age 66.8 years in 2008). Serum glucose, insulin, and hemoglobin A1c were determined from fasting blood in quart-annual exams. Lifestyle and demographic information was self-reported. HRs and 95% confidence intervals (CI) of cancer risk were computed using time-dependent survival analysis (SASv9.3), while accounting for temporal changes for relevant variables.</jats:p> <jats:p>Results: We identified 787 obesity-related cancers, including 136 colorectal, 217 breast, and 219 prostate cancers. Absence versus presence of IFG 10 to 20 years and 20+ years before the event or last follow-up was associated with 44% (95% CI, 1.15–1.79) and 57% (95% CI, 1.17–2.11) increased risk of obesity-related cancers, respectively. When time-dependent variables were used, after adjusting for age, sex, smoking, alcohol, and body mass index, IFG was associated with a 27% increased risk of obesity-related cancer (HR = 1.27; CI, 1.1–1.5). Associations were stronger in smokers (HR = 1.41; CI, 1.13–1.76). Increased risk was noted among persons with higher insulin (HR = 1.47; CI, 1.15–1.88) and hemoglobin A1c (HR = 1.54; CI, 1.13–2.10) for the highest (≥5.73%) versus lowest (≤5.25%) category. A &amp;gt;2-fold increase in colorectal cancer risk was observed for all blood biomarkers of insulin–glucose metabolism, particularly with earlier IFG exposure. Nonsignificant increased risk of breast and prostate cancer was observed for blood biomarkers.</jats:p> <jats:p>Conclusions: Earlier IFG exposure (&amp;gt;10 years before) increased obesity-related cancer risk, particularly for colorectal cancer.</jats:p> <jats:p>Impact: Our study explicitly recognizes the importance of prolonged IFG exposure in identifying links between glucose dysregulation and obesity-related cancers. Cancer Epidemiol Biomarkers Prev; 22(10); 1825–36. ©2013 AACR.</jats:p> Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008) Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Parekh, Niyati, Lin, Yong, Vadiveloo, Maya, Hayes, Richard B., Lu-Yao, Grace L., Cancer Epidemiology, Biomarkers & Prevention, Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008), Oncology, Epidemiology
title Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_full Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_fullStr Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_full_unstemmed Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_short Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
title_sort metabolic dysregulation of the insulin–glucose axis and risk of obesity-related cancers in the framingham heart study-offspring cohort (1971–2008)
title_unstemmed Metabolic Dysregulation of the Insulin–Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971–2008)
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-13-0330